NASDAQ
21.01.25
21:59 Uhr
1,160 US-Dollar
0,000
0,00 %
0,00 %
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02.01. | Shattuck Labs gears up for DR3 antagonist trials in 2025 | 2 | Investing.com | ||
| 02.01. | Shattuck Labs, Inc.: Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2025 | 75 | GlobeNewswire (Europe) | AUSTIN, TX and DURHAM, NC, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor... ► Artikel lesen | |
| 07.12.24 | Redmile Group verkauft Aktien von Shattuck Labs im Wert von 166.713 US-Dollar | 4 | Investing.com Deutsch | ||
| 21.11.24 | Shattuck Labs stock plunges to 52-week low at $1.06 | 1 | Investing.com | ||
| 14.11.24 | Shattuck Labs GAAP EPS of -$0.33 beats by $0.06, revenue of $3M | 1 | Seeking Alpha | ||
| 14.11.24 | Shattuck Labs, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| SHATTUCK LABS Aktie jetzt für 0€ handeln | |||||
| 14.11.24 | Shattuck Labs, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 26.10.24 | Shattuck Labs, Inc. (NASDAQ:STTK) Short Interest Down 60.0% in October | 1 | MarketBeat | ||
| 07.10.24 | Shattuck Labs Aktie erreicht 52-Wochen-Tief bei 1,15 US-Dollar | 1 | Investing.com Deutsch | ||
| 07.10.24 | Shattuck Labs stock hits 52-week low at $1.15 amid market challenges | 2 | Investing.com | ||
| 02.10.24 | Shattuck Labs stock craters following pipeline and job cuts | 2 | Pharmaceutical Technology | ||
| 02.10.24 | STTK Discontinues Cancer Program, Plans Workforce Cut, Stock Falls | 2 | Zacks | ||
| 01.10.24 | Shattuck Labs Shutters Cancer Program, Lays Off Around 40% Of Its Workforce, Reorganizes Pipeline | 2 | Benzinga.com | ||
| 01.10.24 | Shattuck Labs downgraded amid pipeline shift | 2 | Investing.com | ||
| 01.10.24 | Pre-market Movers: Shattuck Labs, SITE Centers, IGM Biosciences, ATIF Holdings, Arqit Quantum | 598 | AFX News | OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 07.45 A.M. ET).In the Green SITE Centers Corp. (SITC) is up over 53% at $18.12.
ATIF... ► Artikel lesen | |
| 01.10.24 | Why Is Shattuck Labs Stock Falling In Pre-market? | 4 | RTTNews | ||
| 01.10.24 | Shattuck Labs ends SL-172154 program, shifts focus to SL-325 | 1 | Investing.com | ||
| 01.10.24 | Shattuck Labs, Inc.: Shattuck Labs Provides Company Update and Announces SL-325, a First-In-Class Death Receptor 3 (DR3) Antagonist Targeting the TL1A/DR3 Signaling Pathway | 75 | GlobeNewswire (Europe) | - Interim clinical data for SL-172154 in combination with azacitidine in TP53 mutant (TP53m) acute myeloid leukemia (AML) and higher-risk myelodysplastic syndromes (HR-MDS) showed only modest improvement... ► Artikel lesen | |
| 01.10.24 | Shattuck Labs, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 28.08.24 | Shattuck Labs stock undervalued amid CD47 concerns, says H.C. Wainwright | 1 | Investing.com |
Seite:
1 2 Weiter >>
32 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TEMPUS AI | 47,590 | 0,00 % | Tempus AI: KI-App 'olivia' und Pelosis Investition treiben Aktienkurs | ||
| IMMUNOVANT | 23,590 | 0,00 % | Immunovant, Inc. (IMVT): The Biotech Stock with Biggest Upside Potential | ||
| SUMMIT THERAPEUTICS | 22,100 | 0,00 % | Why Summit Therapeutics Stock Is Jumping Today | ||
| APOGEE THERAPEUTICS | 39,460 | 0,00 % | Apogee Therapeutics Announces First Participants Dosed in Phase 1 Clinical Trial of APG333, its Novel Half-Life Extended TSLP Antibody for the Treatment of Respiratory and Broader I&I Conditions | Interim safety and pharmacokinetic data from Phase 1 healthy volunteers trial anticipated in 2H 2025 APG777 + APG333 can potentially address key drivers of respiratory diseases more broadly versus... ► Artikel lesen | |
| VERA THERAPEUTICS | 33,700 | 0,00 % | Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | BRISBANE, Calif., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on January 8, 2025, the Compensation Committee granted inducement awards consisting... ► Artikel lesen | |
| RECURSION PHARMACEUTICALS | 6,880 | 0,00 % | Recursion Pharmaceuticals, Inc. (RXRX): Revolutionizing Drug Discovery with AI and Strategic Collaborations for Strong Growth | ||
| QIAGEN | 45,865 | +0,60 % | Qiagen schüttet clever aus | Bei Qiagen profitieren Anleger nicht nur von verbesserten fundamentalen Aussichten: Das Unternehmen schüttet erneut Kapital über einen Reverse Stock Split aus - insgesamt 300 Mio. US-Dollar. Die Venloer... ► Artikel lesen | |
| ADMA BIOLOGICS | 16,200 | 0,00 % | EWTX Yields Over 300% Returns, ADMA Records 200% Gains - Did You Strike While The Iron Is Hot? | WASHINGTON (dpa-AFX) - Biotech investing is a high-stakes game that may not suit the faint-hearted due to its inherent volatility. However, this sector can offer astronomical returns when investors... ► Artikel lesen | |
| HARMONY BIOSCIENCES | 40,420 | 0,00 % | Harmony Biosciences (NASDAQ:HRMY) Earns Buy Rating from HC Wainwright | ||
| QUANTUM-SI | 2,440 | 0,00 % | Quantum-Si Incorporated: Quantum-Si Showcases Advances in Multiomics at the Festival of Genomics UK | Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company, announces its participation in the upcoming Festival of Genomics UK, taking place on... ► Artikel lesen | |
| JANUX THERAPEUTICS | 40,840 | 0,00 % | Pre-market Movers: Cheetah Net Supply Chain Service, NLS Pharmaceutics, PSQ Holdings, Janux Therapeutics, Coherus BioSciences | CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 08.45 A.M. ET).In the Green Cheetah Net Supply Chain Service Inc. (CTNT) is up... ► Artikel lesen | |
| AVIDITY BIOSCIENCES | 30,880 | 0,00 % | Royal Bank of Canada Reiterates Outperform Rating for Avidity Biosciences (NASDAQ:RNA) | ||
| EVOTEC | 7,970 | +0,95 % | Evotec mit positiven News - doch reicht das? | Nachdem es lange ruhig war bei Evotec, hat heute eine Meldung über Fördermittel aus Südkorea wieder für Aufmerksamkeit bei dem Titel gesorgt. Die Aktie von Evotec zählt gegen Mittag zu den sieben stärksten... ► Artikel lesen | |
| BIONTECH | 111,50 | -0,98 % | BioNTech-Aktie: Wird 2025 ein gutes Jahr? | Im vergangenen Jahr hat die BioNTech-Aktie nicht gerade mit einer starken Performance geglänzt. Worauf müssen sich Anleger 2025 einstellen? Was spricht für steigende Kurse, was dagegen? Verhaltener... ► Artikel lesen | |
| KEROS THERAPEUTICS | 11,435 | 0,00 % | Keros spikes as Teva deal takes effect; Cantor downgrades on trial setback |
Das Unternehmen SHATTUCK LABS INC kann der Branche Biotechnologie zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 1,160 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SHATTUCK LABS INC finden Sie auf Wallstreet Online.
